ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors ORIC-944 is a ...

ChangAn Automobile ('ChangAn' or 'the Company'), an intelligent low-carbon mobility technology company, has cemented its future in the European market with its recent official entry. Implementing its ...

Drench in the knowledge with exclusive insights, ePaper & smart market tools with ETPrime.

The Delhi government has presented a 1 lakh crore budget -- a Rs 24000 crore jump. The capital budget has been increased by ...